Group One Trading’s Neos Therapeutics, Inc NEOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-8,605
| Closed | -$5K | – | 8267 |
|
|
2020
Q4 | $5K | Buy |
8,605
+8,278
| +2,531% | +$5.11K | ﹤0.01% | 6067 |
|
|
2020
Q3 | $0 | Hold |
327
| – | – | ﹤0.01% | 6784 |
|
|
2020
Q2 | $0 | Hold |
327
| – | – | ﹤0.01% | 6432 |
|
|
2020
Q1 | $0 | Sell |
327
-4,173
| -93% | -$5.74K | ﹤0.01% | 6014 |
|
|
2019
Q4 | $7K | Hold |
4,500
| – | – | ﹤0.01% | 4702 |
|
|
2019
Q3 | $7K | Buy |
4,500
+2,500
| +125% | +$4.05K | ﹤0.01% | 4700 |
|
|
2019
Q2 | $3K | Sell |
2,000
-13,795
| -87% | -$25.4K | ﹤0.01% | 4731 |
|
|
2019
Q1 | $41K | Sell |
15,795
-50,929
| -76% | -$119K | ﹤0.01% | 3669 |
|
|
2018
Q4 | $110K | Buy |
66,724
+30,990
| +87% | +$87K | ﹤0.01% | 3110 |
|
|
2018
Q3 | $173K | Buy |
35,734
+29,781
| +500% | +$169K | ﹤0.01% | 3110 |
|
|
2018
Q2 | $37K | Sell |
5,953
-32,168
| -84% | -$240K | ﹤0.01% | 4110 |
|
|
2018
Q1 | $316K | Sell |
38,121
-28,859
| -43% | -$276K | ﹤0.01% | 2415 |
|
|
2017
Q4 | $683K | Buy |
66,980
+33,360
| +99% | +$320K | ﹤0.01% | 2002 |
|
|
2017
Q3 | $308K | Buy |
33,620
+20,012
| +147% | +$152K | ﹤0.01% | 2447 |
|
|
2017
Q2 | $99K | Buy |
+13,608
| New | +$103K | ﹤0.01% | 3111 |
|
Group One Trading's NEOS Position: Q1 2021 in Review
Group One Trading sold out of Neos Therapeutics, Inc (NEOS) in Q1 2021, closing a stake of 8,605 shares — an estimated $5K sold.
Group One Trading first reported a position in NEOS in Q2 2017 and held it in 15 quarters. The position peaked at $683K in Q4 2017. 0 funds tracked by Wall St. Rank hold NEOS as of Q1 2021.
- Group One Trading reported no remaining Neos Therapeutics, Inc position as of Q1 2021 after selling out during the quarter.
- Group One Trading sold 8,605 Neos Therapeutics, Inc shares in Q1 2021, an estimated $5K.
- Group One Trading first reported a position in Neos Therapeutics, Inc in Q2 2017 and held it in 15 quarters.
- Group One Trading's Neos Therapeutics, Inc position peaked at $683K in Q4 2017.
- 0 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2021.
Based on Group One Trading's 13F filing for Q1 2021, filed 12 May 2021.